Omniscan

Omniscan is a brand name of gadodiamide, approved by the FDA in the following formulation(s):

OMNISCAN (gadodiamide - injectable; injection)

• 
  Manufacturer: GE HEALTHCARE
  
  Approval date: January 8, 1993
  
  Strength(s): 287MG/ML ^[RLD]


• 
  Manufacturer: GE HEALTHCARE
  
  Approval date: September 5, 2007
  
  Strength(s): 28.7GM/100ML (287MG/ML) ^[RLD]

Has a generic version of Omniscan been approved?

No. There is currently no therapeutically equivalent version of Omniscan available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Omniscan. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Gadolinium chelates for magnetic resonance imaging
  Patent 5,362,475
  Issued: November 8, 1994
  Inventor(s): Gries; Heinz & Rosenberg; Douwe & Weinmann; Hanns-Joachim & Speck; Ulrich & Mutzel; Wolfgang & Hoyer; Georg-Alexander & Pfeiffer, deceased; Heinrich & Renneke; Franz-Josef
  Assignee(s): Schering Aktiengesellschaft
  A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more Gadolinium ions and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
  
  Patent expiration dates:
  
  
  • November 8, 2011
    
    ✓ 
    Drug substance
  
  



• 
  Method of enhancing paramagnetism in chelates for MRI
  Patent 5,560,903
  Issued: October 1, 1996
  Inventor(s): Gries; Heinz & Rosenberg; Douwe & Weinmann; Hanns-Joachim & Speck; Ulrich & Mutzel; Wolfgang & Hoyer; Georg-Alexander & Pfeiffer; Heinrich & Renneke; Franz-Josef
  Assignee(s): Schering Aktiengesellschaft
  A diagnostic medium contains at least one physiologically well tolerated complex salt comprising an anion of a complexing acid and one or more central ion or ions of an element with an atomic number of 21 to 29, 42, 44 or 57 to 83 and, optionally, one or more physiologically biocompatible cation or cations of an inorganic and/or organic base or amino acid, optionally, with additives customary in galenic formulations, dissolved or suspended in an aqueous medium.
  
  Patent expiration dates:
  
  
  • October 1, 2013
    
    ✓ 
    Drug product
  
  

See also...

• Omniscan Advanced Consumer Information (Micromedex)
• Gadodiamide Intravenous Advanced Consumer Information (Micromedex)